
According to a recent New York Times article, doctors in the United Kingdom will be allowed to write prescriptions for medical cannabis as of November 1, 2018.

According to a recent New York Times article, doctors in the United Kingdom will be allowed to write prescriptions for medical cannabis as of November 1, 2018.

Front Range Biosciences (FRB), a leading agricultural biotech company specializing in tissue culture propagation of high value crops, announced in a press release on October 4, 2018 (1), that it has completed a $10 million Series A round of financing for cannabis research.


According to a report from CNBC.com (1), the U.S. Drug Enforcement Administration (DEA) has rescheduled GW Pharmaceuticals’ cannabidiol (CBD)-based drug, Epidiolex, to schedule V.

We recently spoke to Kevin McKernan, the CSO and Founder of Medicinal Genomics, and Doug Kennedy, the CannMed 2018 Conference Director, about their start in the cannabis industry and what to expect from this year’s CannMed conference.


Two U.S. Senators introduced legislation that would allow doctors at the VA to prescribe medical cannabis to veterans in the 31 states that have established medical-marijuana programs.

Priscilla Vilchis, owner and CEO of Premium Produce, was the first licensed female minority in L.A. County, California, and the youngest female minority to be licensed in Nevada. She recently spoke to us about her experience in the cannabis industry, advice for newcomers, and more.

The Cannabis Science Conference, which took place August 28–29, 2018 in Portland, Oregon, saw another year of record-breaking attendance and exhibitors.

Dr. Jacklyn Green, “Dr. Jackie,” CEO of Agate Biosciences, will give a keynote talk today in Rooms A105–A106 starting at 9:50 a.m. The talk is titled “From Feeding Your Head to Feeding the World and Beyond.” Green recently spoke to us about her talk and plans to address the education challenges facing the cannabis industry.

Tracy Ryan, CEO & Founder, CannaKids and Saving Sophie, will give a keynote talk today in Meeting Rooms B113–B116 starting at 9:50 a.m. The talk is titled “Medical Miracles or Simply Science-One Cancer Mom’s Road to a Cure.” Ryan recently spoke to us about her talk and plans to address the research challenges facing the cannabis industry.

Ethan Russo, MD, Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI), will give a keynote talk on Wednesday, August 29, in Exhibit Hall B starting at 9:00 a.m. Russo recently spoke to us about his talk and plans to address the challenge of quality control and standardization in the cannabis industry.

As the plenary speaker for this year’s Cannabis Science Conference, Fran Drescher is once again lending her voice to advocate for change in the cannabis industry. She recently spoke to us about the Cancer Schmancer Movement and her involvement in the cannabis industry.

Bonni Goldstein, MD, Medical Director, Canna Centers Wellness & Education, will give a keynote talk today, Tuesday, August 28, in Meeting Rooms B113–B116 starting at 9:50 a.m.

In advance of today’s Canna Boot Camp, we spoke with Mike Genovese, COO of Chalice Farms, to find out why it’s such a success and how Chalice Farms got involved as the host.


The FDA released a statement this week about reports of severe illnesses and deaths resulting from the use of synthetic cannabinoid products that have been contaminated with brodifacoum.

George Anastassov, the CEO of AXIM Biotech, recently spoke to us about the current good manufacturing methods (cGMPs) his company has developed, their significance to the market, and plans for the future.











